117 related articles for article (PubMed ID: 37715727)
1. An SRF-rearranged malignant cellular myoid neoplasm with a novel SRF-MKL2 fusion.
Crowell C; Schollenberg E; Tran TH; Wilson D; Bezuhly M; Mata-Mbemba D; Antonescu CR; Erker C
Pediatr Blood Cancer; 2023 Dec; 70(12):e30675. PubMed ID: 37715727
[No Abstract] [Full Text] [Related]
2. Novel SRF-ICA1L Fusions in Cellular Myoid Neoplasms With Potential For Malignant Behavior.
Suurmeijer AJ; Dickson BC; Swanson D; Sung YS; Zhang L; Antonescu CR
Am J Surg Pathol; 2020 Jan; 44(1):55-60. PubMed ID: 31478943
[TBL] [Abstract][Full Text] [Related]
3. Dynamic subcellular localization and transcription activity of the SRF cofactor MKL2 in the striatum are regulated by MAPK.
Ariza A; Funahashi Y; Kozawa S; Omar Faruk M; Nagai T; Amano M; Kaibuchi K
J Neurochem; 2021 Jun; 157(6):1774-1788. PubMed ID: 33449379
[TBL] [Abstract][Full Text] [Related]
4. Cellular myofibromas with SRF fusions: clinicopathological and molecular study of 3 cases of a rare entity and a potential mimic of sarcoma.
Papa B; Nguyen MA; Kumar A; Song L; Dorwal P; Cheah AL
Hum Pathol; 2023 Aug; 138():41-48. PubMed ID: 37245628
[TBL] [Abstract][Full Text] [Related]
5. Endogenous SOLOIST/MRTFB i4, a Neuronal Isoform of MKL2/MRTFB, Positively and Negatively Regulates SRF Target Immediate Early Genes in Neuro-2a Cells.
Ihara D; Tanabe H; Takasaki I; Tabuchi A
Biol Pharm Bull; 2023 Aug; 46(8):1141-1144. PubMed ID: 37286514
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in MKL2 and decreased downstream PCTAIRE1 expression in extreme, fatal primary human microcephaly.
Ramos EI; Bien-Willner GA; Li J; Hughes AE; Giacalone J; Chasnoff S; Kulkarni S; Parmacek M; Cole FS; Druley TE
Clin Genet; 2014 May; 85(5):423-32. PubMed ID: 23692340
[TBL] [Abstract][Full Text] [Related]
7. Involvement of SRF coactivator MKL2 in BDNF-mediated activation of the synaptic activity-responsive element in the Arc gene.
Kikuchi K; Ihara D; Fukuchi M; Tanabe H; Ishibashi Y; Tsujii J; Tsuda M; Kaneda M; Sakagami H; Okuno H; Bito H; Yamazaki Y; Ishikawa M; Tabuchi A
J Neurochem; 2019 Jan; 148(2):204-218. PubMed ID: 30244496
[TBL] [Abstract][Full Text] [Related]
8. Megakaryoblastic leukemia-1/2, a transcriptional co-activator of serum response factor, is required for skeletal myogenic differentiation.
Selvaraj A; Prywes R
J Biol Chem; 2003 Oct; 278(43):41977-87. PubMed ID: 14565952
[TBL] [Abstract][Full Text] [Related]
9. SRF Fusions Other Than With RELA Expand the Molecular Definition of SRF-fused Perivascular Tumors.
Karanian M; Kelsey A; Paindavoine S; Duc A; Vanacker H; Hook L; Weinbreck N; Delfour C; Minard V; Baillard P; Blay JY; Pissaloux D; Tirode F
Am J Surg Pathol; 2020 Dec; 44(12):1725-1735. PubMed ID: 33021523
[TBL] [Abstract][Full Text] [Related]
10. SRF and SRF Cofactor mRNA Expression Is Differentially Regulated by BDNF Stimulation in Cortical Neurons.
Ihara D; Miyata T; Fukuchi M; Tsuda M; Tabuchi A
Biol Pharm Bull; 2023 Apr; 46(4):636-639. PubMed ID: 36801840
[TBL] [Abstract][Full Text] [Related]
11. Myocardin-like protein 2 regulates TGFβ signaling in embryonic stem cells and the developing vasculature.
Li J; Bowens N; Cheng L; Zhu X; Chen M; Hannenhalli S; Cappola TP; Parmacek MS
Development; 2012 Oct; 139(19):3531-42. PubMed ID: 22899851
[TBL] [Abstract][Full Text] [Related]
12. Synaptic localisation of SRF coactivators, MKL1 and MKL2, and their role in dendritic spine morphology.
Kaneda M; Sakagami H; Hida Y; Ohtsuka T; Satou N; Ishibashi Y; Fukuchi M; Krysiak A; Ishikawa M; Ihara D; Kalita K; Tabuchi A
Sci Rep; 2018 Jan; 8(1):727. PubMed ID: 29335431
[TBL] [Abstract][Full Text] [Related]
13. Genetic variant of SRF-rearranged myofibroma with a misleading nuclear expression of STAT6 and STAT6 involvement as 3' fusion partner.
Nihous H; Macagno N; Baud-Massière J; Haffner A; Jouve JL; Gentet JC; Touzery C; Le Loarer F; Bouvier C
Virchows Arch; 2021 Mar; 478(3):597-603. PubMed ID: 32529351
[TBL] [Abstract][Full Text] [Related]
14. Ectomesenchymal Chondromyxoid Tumor: A Neoplasm Characterized by Recurrent RREB1-MKL2 Fusions.
Dickson BC; Antonescu CR; Argyris PP; Bilodeau EA; Bullock MJ; Freedman PD; Gnepp DR; Jordan RC; Koutlas IG; Lee CH; Leong I; Merzianu M; Purgina BM; Thompson LDR; Wehrli B; Wright JM; Swanson D; Zhang L; Bishop JA
Am J Surg Pathol; 2018 Oct; 42(10):1297-1305. PubMed ID: 29912715
[TBL] [Abstract][Full Text] [Related]
15. MKL1 and MKL2 play redundant and crucial roles in megakaryocyte maturation and platelet formation.
Smith EC; Thon JN; Devine MT; Lin S; Schulz VP; Guo Y; Massaro SA; Halene S; Gallagher P; Italiano JE; Krause DS
Blood; 2012 Sep; 120(11):2317-29. PubMed ID: 22806889
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling of serum inducible genes identifies a subset of SRF target genes that are MKL dependent.
Selvaraj A; Prywes R
BMC Mol Biol; 2004 Aug; 5():13. PubMed ID: 15329155
[TBL] [Abstract][Full Text] [Related]
17. C11orf95-MKL2 is the resulting fusion oncogene of t(11;16)(q13;p13) in chondroid lipoma.
Huang D; Sumegi J; Dal Cin P; Reith JD; Yasuda T; Nelson M; Muirhead D; Bridge JA
Genes Chromosomes Cancer; 2010 Sep; 49(9):810-8. PubMed ID: 20607705
[TBL] [Abstract][Full Text] [Related]
18. MKLs: co-factors of serum response factor (SRF) in neuronal responses.
Kalita K; Kuzniewska B; Kaczmarek L
Int J Biochem Cell Biol; 2012 Sep; 44(9):1444-7. PubMed ID: 22626970
[TBL] [Abstract][Full Text] [Related]
19. Identification of SRF-E2F1 fusion transcript in EWSR-negative myoepithelioma of the soft tissue.
Urbini M; Astolfi A; Indio V; Tarantino G; Serravalle S; Saponara M; Nannini M; Gronchi A; Fiore M; Maestro R; Brenca M; Dei Tos AP; Dagrada GP; Negri T; Pilotti S; Casali PG; Biasco G; Pession A; Stacchiotti S; Pantaleo MA
Oncotarget; 2017 Sep; 8(36):60036-60045. PubMed ID: 28947952
[TBL] [Abstract][Full Text] [Related]
20. Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression.
Cen B; Selvaraj A; Prywes R
J Cell Biochem; 2004 Sep; 93(1):74-82. PubMed ID: 15352164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
